Overview
Cytognomix, a start-up biotech company based in London, Ontario, is developing novel cytogenetic, single copy DNA probes that are smaller and more densely distributed across the genome than probes that are currently commercially available. The probes will be designed to specifically detect individual chromosomal abnormalities such as those that underlie many diseases.